LADENBURG THALMANN FINANCIAL SERVICES INC. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 189 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$25,000
+13.6%
405
+31.9%
0.00%
Q3 2019$22,000
-50.0%
307
-41.6%
0.00%
Q2 2019$44,000
-2.2%
526
-18.4%
0.00%
Q1 2019$45,000
+32.4%
645
-10.8%
0.00%
Q4 2018$34,000
+41.7%
723
+63.9%
0.00%
Q3 2018$24,000
-66.7%
441
-64.2%
0.00%
-100.0%
Q2 2018$72,0000.0%1,2310.0%0.00%0.0%
Q1 2018$72,000
-10.0%
1,231
-0.2%
0.00%0.0%
Q4 2017$80,000
+27.0%
1,234
+2.5%
0.00%0.0%
Q3 2017$63,000
+6.8%
1,204
-4.5%
0.00%0.0%
Q2 2017$59,000
+3.5%
1,261
+8.4%
0.00%0.0%
Q1 2017$57,000
+35.7%
1,163
+66.1%
0.00%0.0%
Q4 2016$42,000
+2.4%
700
+14.6%
0.00%0.0%
Q3 2016$41,000
+141.2%
611
+102.3%
0.00%
Q2 2016$17,000
+70.0%
302
-2.3%
0.00%
Q1 2016$10,000
-28.6%
3090.0%0.00%
Q4 2015$14,000
+180.0%
309
+153.3%
0.00%
Q3 2015$5,000
-16.7%
122
+11.9%
0.00%
Q2 2015$6,000
-76.0%
109
-73.3%
0.00%
Q1 2015$25,000
+177.8%
409
+63.6%
0.00%
Q2 2014$9,000
-30.8%
250
-37.5%
0.00%
Q1 2014$13,000
+225.0%
400
+92.3%
0.00%
Q4 2013$4,000
+100.0%
208
-3.3%
0.00%
Q3 2013$2,0002150.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 200,000$13,270,00021.02%
Healthcare Value Capital, LLC 50,000$3,318,0005.26%
Consonance Capital Management LP 653,258$43,344,0004.17%
1492 Capital Management LLC 34,500$2,289,0001.87%
JW Asset Management, LLC 29,722$1,972,0001.36%
FRANKLIN STREET ADVISORS INC /NC 29,000$1,924,0000.35%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 55,705$3,696,0000.27%
Ativo Capital Management LLC 15,805$1,049,0000.24%
DIKER MANAGEMENT LLC 9,810$651,0000.23%
CASTLEARK MANAGEMENT LLC 100,615$6,676,0000.20%
View complete list of ANI PHARMACEUTICALS INC shareholders